Navigation Links
Quarter of Disabled Seniors Use Risky Medications

Drugs regarded as ineffective or posing high risk of side effects, analysis finds

WEDNESDAY, May 7 (HealthDay News) -- Senior citizens with disabilities are twice as likely as their non-disabled counterparts to being taking at least one prescription drug deemed inappropriate for people 65 or older, according to new research.

The study, based on 2004 data, reports that about a quarter of disabled seniors in the United States have taken one of 33 medications regarded as ineffective or posing a high risk of side effects to the elderly. These drugs include Xanax, Demerol, Darvon and Procardia.

Only 13 percent of seniors without disabilities used these medications, according to the analysis, published in the latest News and Numbers from the U.S. Agency for Healthcare Research and Quality.

The analysis also found the prescription drug misuse ran slightly higher among people with complex disabilities when compared with those having basic disabilities (27 percent vs. 23 percent). A person is considered to have a complex disability if his or her ability to work or socialize is hindered; a person with only limited ability to walk, bathe or perform everyday activities is said to have a basic disability.

Education, but neither race nor ethnicity, appeared to affect the likelihood that seniors would take an inappropriate medication. Disabled seniors with disabilities who did not finish or receive education beyond high school were more likely to use potentially inappropriate drugs than those who attended college.

The analysis is based on the 2007 National Healthcare Disparities Report, an examination of disparities in access to and quality of health care by race, ethnicity, income and education.

More information

The U.S. Food and Drug Administration has more about medications and older people.

-- Kevin McKeever

SOURCE: Agency for Healthcare Research and Quality, news release, May 6, 2008

Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Haemacure Reports Third Quarter 2007 Results
2. Weight Watchers Declares Quarterly Dividend
3. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
4. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
5. Medical Services International Maintains Pace in Second Quarter
6. Martek Announces Third Quarter 2007 Financial Results
7. Ventas Declares Regular Quarterly Dividend of $0.475 Per Share
8. MDS Reports Third Quarter 2007 Results
9. Authentidate Holding Corp. to Report Fourth Quarter and Fiscal 2007 Year End Results on Thursday, September 13, 2007
10. Hillenbrand Industries Announces Fourth Quarter 2007 Dividend
11. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... ... today announced its strategic partnership with Connance, a healthcare industry leader providing ... companies’ proven, proprietary technology combine to provide health systems, hospitals and ambulatory ...
(Date:6/27/2016)... ... , ... recently awarded their highest five-star rating to Best Buy Eyeglasses, ... the United States and Canada wear eyeglasses. Once considered to be a purely functional ... a fashion statement. Even celebrities use glasses as a way of creating an iconic ...
(Date:6/26/2016)... Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in ... in honor of the city’s history as home to some of the world’s leading ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology ... outcomes platform, Bracket eCOA (SM) 6.0, at the 52 ... 30, 2016 in Philadelphia , Pennsylvania.  A ... product of its kind to fully integrate with RTSM, will ... 6.0 is a flexible platform for electronic clinical outcomes assessments ...
Breaking Medicine Technology: